Table 7.
Variable | 1 (Mean ± SD) |
2 (Mean ± SD) |
---|---|---|
Cholesterol µmol/L_1 | 4.42 ± 0.76 | 4.62 ± 1.02 |
HDL µmol/L_1 | 1.43 ± 0.42 | 1.29 ± 0.37 |
LDL µmol/L_1 | 2.59 ± 0.74 | 2.54 ± 0.79 |
Triglycerides µmol/L_1 | 1.26 ± 0.64 | 1.39 ± 1.11 |
CRP mg/L_1 | 4.2 ± 4.26 | 7.64 ± 12.13 |
WBC × 103/µL_12 | 8.73 ± 2.37 | 9.42 ± 3.1 |
NEUT × 103/µL_12 | 5.22 ± 1.68 | 5.6 ± 2.47 |
LYMPH × 103/µL_12 | 2.04 ± 0.54 | 2.15 ± 0.75 |
MONO × 103/µL_12 | 0.74 ± 0.27 | 1.22 ± 2.03 |
FRAP µmol/L_1 | 0.39 ± 0.22 | 0.41 ± 0.22 |
MDA µmol/L_1 | 0.75 ± 0.16 | 0.78 ± 0.14 |
PON1 U/L_1 | 102.08 ± 5.99 | 102.04 ± 3.3 |
FRAP saliva_1 | 0.42 ± 0.25 | 0.57 ± 0.34 |
AVG | 339.78 ± 40.8 | 336.86 ± 31.12 |
DWI left frontal lobe DEV | 31.4 ± 6.42 | 30.04 ± 5.68 |
DWI_ACC right AVG | 429.41 ± 49.67 | 441.41 ± 45.17 |
DWI_ACC right DEV | 55.29 ± 10.24 | 52.12 ± 6.98 |
DWI_ACC left AVG | 419.83 ± 35.17 | 434.89 ± 50.5 |
DWI_ACC left DEV | 54.97 ± 9.85 | 52.15 ± 9.92 |
FA right frontal lobe AVG | 0.39 ± 0.04 | 0.39 ± 0.04 |
FA right frontal lobe DEV | 0.11 ± 0.01 | 0.1 ± 0.02 |
FA left frontal lobe AVG | 0.36 ± 0.04 | 0.35 ± 0.1 |
FA left frontal lobe DEV | 0.1 ± 0.03 | 0.1 ± 0.02 |
FA_ACC right AVG | 0.21 ± 0.05 | 0.22 ± 0.04 |
FA_ACC right DEV | 0.11 ± 0.04 | 0.13 ± 0.03 |
FA_ACC left AVG | 0.19 ± 0.03 | 0.2 ± 0.04 |
FA_ACC left DEV | 0.13 ± 0.13 | 0.11 ± 0.02 |
ACC_MI | 9,539,129 ± 2,765,434 | 8,952,829 ± 3,612,834 |
ACC_MICR | 0.77 ± 0.18 | 0.69 ± 0.17 |
ACC_MICR_A | 0.37 ± 0.33 | 0.2 ± 0.13 |
(1) 0–2.5 mU/L; (2) >2.5 mU/L; _1—results during the first week of hospitalization; _12—results three months after admission to the hospital; ACC—anterior cingulate cortex; AVG—average; CR—creatine; CRP—C-reactive protein; DEV—standard deviation; DWI—diffusion-weighted imaging; FA—fractional anisotropy; FRAP—Ferric reducing the ability of plasma; HDL—high-density lipoprotein; LDL—low-density lipoprotein; LYMP—lymphocytes; MDA—malondialdehyde; MI—myoinositol; MONO—monocytes; NEUT—neutrophils; PON1—paraoxonase-1; WBC—white blood cells.